Search

everythinglearnresearchcommunity

for

Search:↓

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Minoxidil may protect the brain from damage by preventing cell death and energy loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Letrozole reduces seizures but not brain damage in mice.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Oral baricitinib is effective and safe for treating alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Vorasidenib can cause unusual hair growth.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tamsulosin increases the risk of floppy iris during eye surgery.